Mags Tanev, our co-host here at Brains Byte Back, brings the second installment of her series The New Era of Psychedelics, exploring scientific research, therapies, and the potential benefits of psychedelic compounds and plant medicines in our societies.
In this episode, Tanev interviews Gaurav Dubey, a clinical biologist, and science blogger, to discuss research surrounding microdosing, the benefits of microdosing vs. other types of psychedelic use, and changing attitudes towards microdosing and psychedelics in our society.
Listen to this podcast on Spotify, Anchor, Apple Podcasts, Breaker, Google Podcasts, Stitcher, Overcast, Listen Notes, and Radio Public.
In addition to Dubey, Tanev also speaks with a psychedelics enthusiast with a high level of microdosing experience who wanted to keep his identity anonymous.
Neural rights was a hot topic during a session called "Approaching Singularity: Our Brains Interfacing…
At some point in the last 10 years, I started viewing Colonel John Boyd as…
When I started designing an AI Evaluation pipeline/framework at my organization, I had no idea…
This week software firm Source Meridian announced that Bob Reisenweber was named its new Director…
The early wave of AI disruption focused on the tech's ability to work as a…
DARPA GO could be used for human performance enhancement & bioengineered super-soldiers, along with the…
View Comments